G

Global Blood Therapeutics

348 employees

GBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease.

Investor insights

Sectors invested in

Health Care3

Charity2

resources1

nonprofit1

sickle cell1

advocacy1

Funding rounds participated in

$50K sweet spot round size

Most of their 5 investments are in rounds between $50K and $50K

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Therapeutics

Genetics

Medical

Date founded

2011

Investments made

A

ADVANCING SICKLE CELL ADVOCACY PROJECT INC raised $50K on July 13, 2022

Investors: Global Blood Therapeutics

C

Children's Sickle Cell Foundation, Inc. raised $50K on July 13, 2022

Investors: Global Blood Therapeutics

U

Undisclosed raised $50K on July 13, 2022

Investors: Global Blood Therapeutics

S

Sickle Cell Warriors raised $50K on July 13, 2022

Investors: Global Blood Therapeutics

S

Sickle Cell Association of South Louisiana raised $50K on July 13, 2022

Investors: Global Blood Therapeutics

Funding rounds raised

Total raised

$48M

from 3 investors over 3 rounds

G

Global Blood Therapeutics raised $48M on January 6, 2015

Investors: RA Capital Management, L.P. and Wellington Management

G

Global Blood Therapeutics raised $41M on June 14, 2012

Investors: Third Rock Ventures

FAQ